共 60 条
[1]
Smyth S(2006)Diabetes and obesity: the twin epidemics Nat Med 12 75-80
[2]
Heron A(2006)Mechanisms linking obesity to insulin resistance and type 2 diabetes Nature 444 840-846
[3]
Kahn SE(2002)The mechanisms of action of PPARs Ann Rev Med 53 409-435
[4]
Hull RL(2010)Revisiting the rosiglitazone story—lessons learned N Engl J Med 363 803-806
[5]
Utzschneider KM(2005)Peroxisome proliferator-activated receptor gamma: the more the merrier? Eur J Clin Investig 35 82-92
[6]
Berger J(2004)Peroxisome proliferator-activated receptor-gamma: too much of a good thing causes harm EMBO Rep 5 142-147
[7]
Moller DE(2004)Principles for modulation of the nuclear receptor superfamily Nat Rev Drug Discov 3 950-964
[8]
Rosen CJ(2006)Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the treatment of type 2 diabetes and atherosclerosis Expert Opin Emerg Drugs 11 379-401
[9]
Argmann CA(2012)Amorfrutins are potent antidiabetic dietary natural products Proc Natl Acad Sci USA 109 7257-7262
[10]
Cock TA(2013)Structural characterization of amorfrutins bound to the peroxisome proliferator-activated receptor gamma J Med Chem. 56 1535-1543